search
Back to results

Collagen Cross-linking in Infectious Keratitis Trial

Primary Purpose

Infectious Keratitis, Bacterial Keratitis, Fungal Keratitis

Status
Completed
Phase
Phase 2
Locations
Thailand
Study Type
Interventional
Intervention
Collagen cross-linking
Sponsored by
Chulalongkorn University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infectious Keratitis focused on measuring corneal ulcer, keratitis

Eligibility Criteria

6 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Evidence of corneal ulcer grade II or III (bacteria or fungal, or presumed bacterial or fungal)
  • Age more than 6 year
  • Patients can understand and can follow the study protocol

Exclusion Criteria:

  • Pregnancy by history or urine test
  • Evidence of herpetic keratitis
  • Evidence of corneal perforation
  • Evidence of autoimmune disease
  • Known allergy to study medication

Sites / Locations

  • Ophthalmology department, King Chulalongkorn Memorial hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Collagen cross-linking

standard treatment

Arm Description

Collagen cross-linking with standard treatment

Standard treatment alone

Outcomes

Primary Outcome Measures

decrement of infiltration size
decrement of infiltration size between day0 and day 30

Secondary Outcome Measures

number of participants with adverse events
adverse events after corneal collagen cross-linking (report in descriptive study)

Full Information

First Posted
April 6, 2013
Last Updated
May 1, 2015
Sponsor
Chulalongkorn University
search

1. Study Identification

Unique Protocol Identification Number
NCT01831206
Brief Title
Collagen Cross-linking in Infectious Keratitis Trial
Official Title
Collagen Cross-linking in Infectious Keratitis Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
March 2013 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
December 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chulalongkorn University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infectious Keratitis, Bacterial Keratitis, Fungal Keratitis
Keywords
corneal ulcer, keratitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Collagen cross-linking
Arm Type
Experimental
Arm Description
Collagen cross-linking with standard treatment
Arm Title
standard treatment
Arm Type
No Intervention
Arm Description
Standard treatment alone
Intervention Type
Procedure
Intervention Name(s)
Collagen cross-linking
Intervention Description
Collagen cross-linking arm will receive standard medication for corneal ulcer treatment and corneal collagen cross-linking. Standard treatment arm will receive only standard medication.
Primary Outcome Measure Information:
Title
decrement of infiltration size
Description
decrement of infiltration size between day0 and day 30
Time Frame
1 months
Secondary Outcome Measure Information:
Title
number of participants with adverse events
Description
adverse events after corneal collagen cross-linking (report in descriptive study)
Time Frame
1 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Evidence of corneal ulcer grade II or III (bacteria or fungal, or presumed bacterial or fungal) Age more than 6 year Patients can understand and can follow the study protocol Exclusion Criteria: Pregnancy by history or urine test Evidence of herpetic keratitis Evidence of corneal perforation Evidence of autoimmune disease Known allergy to study medication
Facility Information:
Facility Name
Ophthalmology department, King Chulalongkorn Memorial hospital
City
Pratumwan
State/Province
Bangkok
ZIP/Postal Code
10330
Country
Thailand

12. IPD Sharing Statement

Citations:
PubMed Identifier
32557558
Citation
Davis SA, Bovelle R, Han G, Kwagyan J. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020 Jun 17;6(6):CD013001. doi: 10.1002/14651858.CD013001.pub2.
Results Reference
derived

Learn more about this trial

Collagen Cross-linking in Infectious Keratitis Trial

We'll reach out to this number within 24 hrs